Clinicopathological significance of abnormalities in Gadd45 expression and its relationship to p53 in human pancreatic cancer

Clinical Cancer Research

Volumn 8, Issue 8, 2002, Pages 2563-2569

  Yamasawa, Kunihiro ^a   Nio, Yoshinori ^a   Dong, Ming ^a   Yamaguchi, Kazushige ^a   Itakura, Masayuki ^a  

^a SHIMANE UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; GENE PRODUCT; PROTEIN GADD45A; PROTEIN P53; TUMOR PROTEIN; UNCLASSIFIED DRUG; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; PROTEIN; SIGNAL PEPTIDE;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; CANCER GRADING; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; DNA SEQUENCE; EXON; FEMALE; GENE EXPRESSION; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LINIMENT; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NUCLEOTIDE SEQUENCE; PANCREAS CANCER; POINT MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEQUENCE ANALYSIS; SURVIVAL RATE; CELL CULTURE; CELL NUCLEUS; CYTOPLASM; DNA REPAIR; GENETICS; METABOLISM; MIDDLE AGED; MORTALITY; MUTATION; PANCREAS CARCINOMA; PANCREAS TUMOR; PROTEIN SYNTHESIS; SEX DIFFERENCE; TIME; TUMOR SUPPRESSOR GENE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, PANCREATIC DUCTAL; CELL NUCLEUS; CYTOPLASM; DNA REPAIR; EXONS; FEMALE; GENES, P53; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGE; MULTIVARIATE ANALYSIS; MUTATION; PANCREATIC NEOPLASMS; POINT MUTATION; PROTEIN P53; PROTEINS; SEQUENCE ANALYSIS, DNA; SEX FACTORS; TIME FACTORS; TUMOR CELLS, CULTURED; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MIDDLE AGED; PROTEIN BIOSYNTHESIS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0036023416     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving?
2. Apoptosis and expression of Bcl-2 and Bax proteins in invasive ductal carcinoma of the pancreas
3. p53 protein expression as prognostic factor in human pancreatic cancer
4. Clinicopathological significance of Ki-ras point mutation and p21 expression in benign and malignant exocrine tumors of the human pancreas
5. Ki-ras point mutation and p53 expression in human pancreatic cancer: A comparative study among Chinese, Japanese, and Western patients
6. Clinicopathological significance of epidermal growth factor and its receptor in human pancreatic cancer
7. WAFI/CIPI expression and prognosis in resectable invasive ductal carcinoma of the pancreas
8. Comparative significance of p53 and WAF/1-p21 expression on the efficacy of adjuvant chemotherapy for resectable invasive ductal carcinoma of the pancreas
9. Creative blocks: Cell-cycle checkpoints and feedback controls
10. Cell cycle checkpoints: Preventing an identity crisis
11. Viewpoint: Putting the cell cycle in order
12. Wild-type p53 is a cell cycle checkpoint determinant following irradiation
13. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia
14. Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen
15. New link found between p53 and DNA repair
16. A polymorphism but no mutations in the GADD45 gene in breast cancers
17. Gadd45 mutations are uncommon in human tumour cell lines
18. Purification of DNA from formaldehyde-fixed and paraffin-embedded human tissue
19. An immunochemical analysis of the human nuclear phosphoprotein p53. New monoclonal antibodies and epitope mapping using recombinant p53
20. Localization of p53, retinoblastoma and host replication proteins at sites of viral replication in herpes-infected cells
21. Small subgroup of aggressive, highly proliferative prostatic carcinomas defined by p53 accumulation
22. p53 protein expression in breast cancer as related to histopathological characteristics and prognosis
23. Overexpression of p53 protein in adenocarcinoma of the pancreas
24. Induction by ionizing radiation of the gadd45 gene in cultured human cells: Lack of mediation by protein kinase C
25. DNA damage-inducible transcripts in mammalian cells
26. Response to adversity: Molecular control of gene activation following genotoxic stress
27. Analysis of the mammalian gadd45 gene and its response to DNA damage
28. Molecular cloning, expression, and mapping of a novel human cDNA, GRP17, highly homologous to human gadd45 and murine MyD118
29. Genomic instability in Gadd45a-deficient mice
30. p53 mutations are common in pancreatic cancer and are absent in chronic pancreatitis
31. Clinical implications of the p53 tumor-suppressor gene
32. The p53-mdm-2 autoregulatory feedback loop
33. The importance of p53 gene alterations in human cancer: Is there more than circumstantial evidence?
34. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation
35. Regulation of p53 downstream genes
36. The molecular basis for cell cycle delays following ionizing radiation: A review
37. 2/M cell cycle checkpoint
38. An informatics approach identifying markers of chemosensitivity in human cancer cell lines
39. Characterization of the GADD45 response to ionizing radiation in WI-L2-NS cells, a p53 mutant cell line
40. Characterization of human Gadd45, a p53-regulated protein
41. The gadd and MyD genes define a novel set of mammalian genes encoding acidic proteins that synergistically suppress cell growth
42. p53 and related proteins in epithelial ovarian cancer
43. Radiation-induced gadd45 expression correlates with clinical response to radiotherapy of cervical carcinoma
44. Comparative gene expression profiling in response to p53 in a human lung cancer cell line